Gram-negative bacteria, HLA-B27 and inflammatory bowel disease.
Lymphocytes from 48 IBD patients including nine with HLA-B27 were examined for their capacity to absorb Y.enterocolitica 0:9 antiserum. They possessed a range of absorption ability which was unconnected with HLA-B27 status. Samples of lymphocytes from 28 AS patients, 10 RA patients and 28 normal control subjects were included for comparison. The significance of the findings is discussed.
Pease
P E
PE
Lane
M R
MR
Chahal
H
H
Tallack
J E
JE
Allan
R N
RN
D001172:Arthritis, Rheumatoid / Q000276:immunology; D003093:Colitis, Ulcerative / Q000276:immunology*; D003424:Crohn Disease / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D006680:HLA Antigens / Q000032:analysis*; D015796:HLA-B27 Antigen; D006801:Humans; D008214:Lymphocytes / Q000276:immunology*; D013167:Spondylitis, Ankylosing / Q000276:immunology; D015008:Yersinia enterocolitica / Q000276:immunology*
D006680:HLA Antigens; D015796:HLA-B27 Antigen